(-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Paraquat results in increased expression of DIABLO protein] CTD PMID:17936647 (-)-epigallocatechin 3-gallate affects localization ISO DIABLO (Homo sapiens) 6480464 epigallocatechin gallate analog affects the localization of DIABLO protein CTD PMID:16115949 (R,R,R)-alpha-tocopherol affects localization ISO Diablo (Mus musculus) 6480464 alpha-Tocopherol affects the localization of DIABLO protein CTD PMID:15582575 1,2-dimethylhydrazine multiple interactions ISO Diablo (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of DIABLO mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO Diablo (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of DIABLO mRNA CTD PMID:22206623 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO DIABLO (Homo sapiens) 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Diablo (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DIABLO mRNA CTD PMID:20702594 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DIABLO mRNA CTD PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Diablo (Mus musculus) 6480464 2 more ... CTD PMID:20702594 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of DIABLO mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol multiple interactions EXP 6480464 Butylated Hydroxytoluene inhibits the reaction [ganglioside more ... CTD PMID:14987999 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of DIABLO mRNA CTD PMID:21346803 2-methylcholine affects expression ISO DIABLO (Homo sapiens) 6480464 beta-methylcholine affects the expression of DIABLO mRNA CTD PMID:21179406 3-phenylprop-2-enal multiple interactions ISO DIABLO (Homo sapiens) 6480464 Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein] CTD PMID:15566391 3-phenylprop-2-enal affects localization ISO DIABLO (Homo sapiens) 6480464 cinnamaldehyde affects the localization of DIABLO protein CTD PMID:15566391 4,4'-sulfonyldiphenol increases expression ISO Diablo (Mus musculus) 6480464 bisphenol S results in increased expression of DIABLO mRNA CTD PMID:31881267 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DIABLO mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol decreases expression ISO DIABLO (Homo sapiens) 6480464 bisphenol S results in decreased expression of DIABLO protein CTD PMID:31945527 4-nitrophenol decreases expression ISO Diablo (Mus musculus) 6480464 4-nitrophenol results in decreased expression of DIABLO mRNA CTD PMID:34673133 5-fluorouracil increases response to substance ISO DIABLO (Homo sapiens) 6480464 DIABLO protein results in increased susceptibility to Fluorouracil CTD PMID:18031615 5-fluorouracil increases expression ISO DIABLO (Homo sapiens) 6480464 Fluorouracil results in increased expression of DIABLO mRNA CTD PMID:16557594 6-bromoindirubin-3'-oxime multiple interactions ISO DIABLO (Homo sapiens) 6480464 6-bromoindirubin-3'-oxime promotes the reaction [sorafenib affects the localization of DIABLO protein] CTD PMID:17991738 acetylsalicylic acid decreases expression ISO DIABLO (Homo sapiens) 6480464 Aspirin results in decreased expression of DIABLO protein CTD PMID:15976387 adenosine increases expression ISO DIABLO (Homo sapiens) 6480464 Adenosine results in increased expression of DIABLO mRNA and Adenosine results in increased expression of DIABLO protein CTD PMID:20063052 adenosine multiple interactions ISO DIABLO (Homo sapiens) 6480464 Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO mRNA] and Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO protein] CTD PMID:20063052 afatinib multiple interactions ISO DIABLO (Homo sapiens) 6480464 [CALM2 protein affects the susceptibility to Afatinib] which affects the localization of DIABLO protein CTD PMID:36460225 aldehydo-D-glucose multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 aldehydo-D-glucose increases expression ISO DIABLO (Homo sapiens) 6480464 Glucose results in increased expression of DIABLO mRNA CTD PMID:33962019 all-trans-retinoic acid multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Tretinoin co-treated with Paclitaxel] affects the localization of DIABLO protein more ... CTD PMID:17701358 more ... all-trans-retinoic acid increases expression ISO DIABLO (Homo sapiens) 6480464 Tretinoin results in increased expression of DIABLO protein CTD PMID:17701358 alvocidib affects localization ISO DIABLO (Homo sapiens) 6480464 alvocidib affects the localization of DIABLO protein CTD PMID:12517783 alvocidib multiple interactions ISO DIABLO (Homo sapiens) 6480464 [alvocidib co-treated with Bortezomib] results in increased secretion of DIABLO protein more ... CTD PMID:12231544 more ... ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of DIABLO protein CTD PMID:16483693 aristolochic acid A increases expression ISO DIABLO (Homo sapiens) 6480464 aristolochic acid I results in increased expression of DIABLO mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO Diablo (Mus musculus) 6480464 arsenite results in decreased expression of DIABLO mRNA CTD PMID:33053406 arsenite(3-) multiple interactions ISO DIABLO (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to DIABLO mRNA] CTD PMID:32406909 arsenous acid multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of DIABLO protein CTD PMID:27430728 aspartame multiple interactions ISO Diablo (Mus musculus) 6480464 [Fats more ... CTD PMID:23783067 bisphenol A increases expression ISO DIABLO (Homo sapiens) 6480464 bisphenol A results in increased expression of DIABLO mRNA and bisphenol A results in increased expression of DIABLO protein CTD PMID:25047013 and PMID:37567409 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DIABLO mRNA CTD PMID:36041667 bisphenol A multiple interactions ISO DIABLO (Homo sapiens) 6480464 [[ginger extract results in increased abundance of Oils and Volatile] which co-treated with bisphenol A] affects the expression of DIABLO protein CTD PMID:33376534 bisphenol A decreases expression ISO DIABLO (Homo sapiens) 6480464 bisphenol A results in decreased expression of DIABLO mRNA CTD PMID:29275510 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of DIABLO mRNA CTD PMID:25181051 Bisphenol A diglycidyl ether affects localization ISO DIABLO (Homo sapiens) 6480464 2 and 2-bis(4-glycidyloxyphenyl)propane affects the localization of DIABLO protein CTD PMID:12788809 Bisphenol B increases expression ISO DIABLO (Homo sapiens) 6480464 bisphenol B results in increased expression of DIABLO protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DIABLO mRNA CTD PMID:36041667 bortezomib affects localization ISO DIABLO (Homo sapiens) 6480464 Bortezomib affects the localization of DIABLO protein CTD PMID:16024631 bortezomib increases localization ISO DIABLO (Homo sapiens) 6480464 Bortezomib results in increased localization of DIABLO protein CTD PMID:14555532 bortezomib increases expression ISO DIABLO (Homo sapiens) 6480464 Bortezomib results in increased expression of DIABLO mRNA and Bortezomib results in increased expression of DIABLO protein CTD PMID:17327374 and PMID:25913414 bortezomib multiple interactions ISO DIABLO (Homo sapiens) 6480464 [alvocidib co-treated with Bortezomib] results in increased secretion of DIABLO protein more ... CTD PMID:12893773 more ... Butylparaben increases expression ISO DIABLO (Homo sapiens) 6480464 butylparaben results in increased expression of DIABLO mRNA CTD PMID:24481588 cadmium atom multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIABLO mRNA CTD PMID:35301059 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of DIABLO mRNA CTD PMID:21297351 cadmium dichloride multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIABLO mRNA CTD PMID:35301059 cannabidiol affects localization ISO DIABLO (Homo sapiens) 6480464 Cannabidiol affects the localization of DIABLO protein CTD PMID:31699976 cannabidiol multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of DIABLO mRNA more ... CTD PMID:30096889 and PMID:31699976 cannabidiol decreases expression ISO DIABLO (Homo sapiens) 6480464 Cannabidiol results in decreased expression of DIABLO mRNA CTD PMID:27714895 cannabidiol increases expression ISO DIABLO (Homo sapiens) 6480464 Cannabidiol results in increased expression of DIABLO protein CTD PMID:31699976 cerivastatin increases localization ISO DIABLO (Homo sapiens) 6480464 cerivastatin results in increased localization of DIABLO protein CTD PMID:15705602 chromium(6+) affects localization ISO DIABLO (Homo sapiens) 6480464 chromium hexavalent ion affects the localization of DIABLO protein CTD PMID:16166740 chromium(6+) multiple interactions ISO DIABLO (Homo sapiens) 6480464 TP53 protein affects the reaction [chromium hexavalent ion affects the localization of DIABLO protein] CTD PMID:16166740 chrysazin increases expression ISO DIABLO (Homo sapiens) 6480464 danthron results in increased expression of DIABLO protein CTD PMID:21126053 cinchocaine multiple interactions EXP 6480464 Dibucaine inhibits the reaction [Paraquat affects the localization of DIABLO protein] CTD PMID:25947082 cisplatin increases response to substance ISO DIABLO (Homo sapiens) 6480464 DIABLO protein results in increased susceptibility to Cisplatin CTD PMID:18031615 and PMID:21204765 cladribine multiple interactions ISO DIABLO (Homo sapiens) 6480464 Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased localization of DIABLO protein] CTD PMID:12948851 clobetasol decreases expression ISO Diablo (Mus musculus) 6480464 Clobetasol results in decreased expression of DIABLO mRNA CTD PMID:27462272 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DIABLO mRNA CTD PMID:17602206 corosolic acid decreases expression ISO DIABLO (Homo sapiens) 6480464 corosolic acid results in decreased expression of DIABLO mRNA and corosolic acid results in decreased expression of DIABLO protein CTD PMID:28506699 curcumin affects localization ISO Diablo (Mus musculus) 6480464 Curcumin affects the localization of DIABLO protein CTD PMID:17277231 curcumin multiple interactions ISO DIABLO (Homo sapiens) 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of DIABLO protein CTD PMID:27430728 curcumin increases expression ISO DIABLO (Homo sapiens) 6480464 Curcumin results in increased expression of DIABLO mRNA CTD PMID:23555722 curcumin increases response to substance ISO Diablo (Mus musculus) 6480464 DIABLO protein results in increased susceptibility to Curcumin CTD PMID:17277231 cyclosporin A multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [Paraquat affects the localization of DIABLO protein] CTD PMID:25947082 cylindrospermopsin increases expression ISO DIABLO (Homo sapiens) 6480464 cylindrospermopsin results in increased expression of DIABLO mRNA CTD PMID:23726867 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of DIABLO mRNA CTD PMID:29038839 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 D-glucose increases expression ISO DIABLO (Homo sapiens) 6480464 Glucose results in increased expression of DIABLO mRNA CTD PMID:33962019 D-glucose multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 desferrioxamine B increases expression ISO DIABLO (Homo sapiens) 6480464 Deferoxamine results in increased expression of DIABLO mRNA CTD PMID:33962019 desferrioxamine B multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 dexamethasone affects localization ISO DIABLO (Homo sapiens) 6480464 Dexamethasone affects the localization of DIABLO protein CTD PMID:12855565 dexamethasone multiple interactions ISO DIABLO (Homo sapiens) 6480464 [GCS-100 co-treated with Dexamethasone] affects the localization of DIABLO protein CTD PMID:16166312 diallyl disulfide decreases localization ISO DIABLO (Homo sapiens) 6480464 diallyl disulfide results in decreased localization of DIABLO protein CTD PMID:17647244 Diallyl sulfide decreases localization ISO DIABLO (Homo sapiens) 6480464 allyl sulfide results in decreased localization of DIABLO protein CTD PMID:17647244 diarsenic trioxide multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of DIABLO protein CTD PMID:27430728 diazinon affects expression EXP 6480464 Diazinon affects the expression of DIABLO mRNA CTD PMID:22546817 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Paraquat affects the localization of DIABLO protein] CTD PMID:25947082 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of DIABLO mRNA CTD PMID:22546817 diepoxybutane increases expression ISO DIABLO (Homo sapiens) 6480464 diepoxybutane results in increased expression of DIABLO mRNA CTD PMID:29792945 dioscin increases expression ISO DIABLO (Homo sapiens) 6480464 dioscin results in increased expression of DIABLO mRNA CTD PMID:29990575 dioxygen multiple interactions ISO DIABLO (Homo sapiens) 6480464 3-hydroxy-4-pentenoic acid promotes the reaction [Oxygen deficiency results in increased secretion of DIABLO protein] CTD PMID:17671207 dipyridamole multiple interactions ISO DIABLO (Homo sapiens) 6480464 Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO mRNA] and Dipyridamole inhibits the reaction [Adenosine results in increased expression of DIABLO protein] CTD PMID:20063052 dorsomorphin multiple interactions ISO DIABLO (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIABLO mRNA CTD PMID:27188386 doxorubicin increases expression ISO DIABLO (Homo sapiens) 6480464 Doxorubicin results in increased expression of DIABLO mRNA CTD PMID:17521628 and PMID:33507000 doxorubicin multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Doxorubicin co-treated with Melatonin] results in increased expression of DIABLO protein more ... CTD PMID:33507000 and PMID:37345903 Echinocystic acid affects localization ISO DIABLO (Homo sapiens) 6480464 echinocystic acid analog affects the localization of DIABLO protein CTD PMID:15863893 entinostat multiple interactions ISO DIABLO (Homo sapiens) 6480464 [fludarabine co-treated with entinostat] results in increased secretion of DIABLO protein CTD PMID:15059916 epichlorohydrin decreases expression ISO DIABLO (Homo sapiens) 6480464 Epichlorohydrin results in decreased expression of DIABLO mRNA CTD PMID:29792945 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of DIABLO mRNA CTD PMID:29038839 fenthion decreases expression ISO Diablo (Mus musculus) 6480464 Fenthion results in decreased expression of DIABLO mRNA CTD PMID:34813904 flutamide increases expression EXP 6480464 Flutamide results in increased expression of DIABLO mRNA CTD PMID:24136188 flutamide multiple interactions ISO Diablo (Mus musculus) 6480464 CBL protein affects the reaction [Flutamide results in increased expression of DIABLO protein] and Flutamide inhibits the reaction [CBL protein affects the expression of DIABLO protein] CTD PMID:16301331 flutamide increases expression ISO Diablo (Mus musculus) 6480464 Flutamide results in increased expression of DIABLO protein CTD PMID:16301331 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DIABLO mRNA CTD PMID:24793618 folic acid increases expression ISO Diablo (Mus musculus) 6480464 Folic Acid results in increased expression of DIABLO mRNA and Folic Acid results in increased expression of DIABLO protein CTD PMID:12969128 folic acid multiple interactions ISO Diablo (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of DIABLO mRNA] CTD PMID:22206623 fomepizole multiple interactions ISO Diablo (Mus musculus) 6480464 Fomepizole inhibits the reaction [Acetaminophen affects the localization of DIABLO protein] CTD PMID:29739258 fumonisin B1 decreases expression ISO DIABLO (Homo sapiens) 6480464 fumonisin B1 results in decreased expression of DIABLO protein CTD PMID:25800559 glucose increases expression ISO DIABLO (Homo sapiens) 6480464 Glucose results in increased expression of DIABLO mRNA CTD PMID:33962019 glucose multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA and Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA] CTD PMID:33962019 hydrogen peroxide multiple interactions EXP 6480464 Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of DIABLO protein] CTD PMID:14987999 hydrogen peroxide affects expression ISO DIABLO (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of DIABLO protein CTD PMID:21179406 hydrogen peroxide increases secretion EXP 6480464 Hydrogen Peroxide results in increased secretion of DIABLO protein CTD PMID:14987999 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of DIABLO mRNA CTD PMID:21396975 ivermectin decreases expression ISO DIABLO (Homo sapiens) 6480464 Ivermectin results in decreased expression of DIABLO protein CTD PMID:32959892 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of DIABLO mRNA CTD PMID:19700661 lamivudine multiple interactions ISO Diablo (Mus musculus) 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA CTD PMID:18313992 LGK974 multiple interactions ISO DIABLO (Homo sapiens) 6480464 LGK974 inhibits the reaction [Paraquat results in increased transport of DIABLO protein] CTD PMID:30205152 melatonin multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Doxorubicin co-treated with Melatonin] results in increased expression of DIABLO protein more ... CTD PMID:33507000 and PMID:33962019 melatonin increases expression ISO DIABLO (Homo sapiens) 6480464 Melatonin results in increased expression of DIABLO mRNA and Melatonin results in increased expression of DIABLO protein CTD PMID:33507000 metformin multiple interactions ISO Diablo (Mus musculus) 6480464 Metformin inhibits the reaction [Acetaminophen affects the localization of DIABLO protein] CTD PMID:27562556 minocycline decreases secretion ISO Diablo (Mus musculus) 6480464 Minocycline results in decreased secretion of DIABLO protein CTD PMID:12930891 minocycline multiple interactions EXP 6480464 Minocycline inhibits the reaction [HTT protein mutant form results in increased secretion of DIABLO protein] and Minocycline results in decreased secretion of and results in decreased expression of DIABLO protein CTD PMID:12930891 and PMID:14998631 mono(2-ethylhexyl) phthalate increases expression ISO DIABLO (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of DIABLO protein CTD PMID:24706461 mono(2-ethylhexyl) phthalate decreases expression ISO Diablo (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of DIABLO mRNA CTD PMID:18755736 monosodium L-glutamate multiple interactions ISO Diablo (Mus musculus) 6480464 [Fats more ... CTD PMID:23783067 morin increases expression ISO DIABLO (Homo sapiens) 6480464 morin results in increased expression of DIABLO mRNA CTD PMID:28689916 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO DIABLO (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cannabidiol promotes the reaction [DIABLO protein binds to XIAP protein]] CTD PMID:31699976 N-nitrosodiethylamine multiple interactions EXP 6480464 [3 more ... CTD PMID:17602206 and PMID:27048571 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of DIABLO mRNA CTD PMID:24136188 nitric oxide affects localization ISO DIABLO (Homo sapiens) 6480464 Nitric Oxide affects the localization of DIABLO protein CTD PMID:15126337 ochratoxin A decreases expression ISO DIABLO (Homo sapiens) 6480464 ochratoxin A results in decreased expression of DIABLO mRNA CTD PMID:17316727 oleanolic acid multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Oleanolic Acid results in increased susceptibility to Doxorubicin] which affects the expression of DIABLO mRNA CTD PMID:37345903 p-menthan-3-ol increases expression ISO DIABLO (Homo sapiens) 6480464 Menthol results in increased expression of DIABLO mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO DIABLO (Homo sapiens) 6480464 [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein more ... CTD PMID:14749477 more ... paclitaxel affects localization ISO DIABLO (Homo sapiens) 6480464 Paclitaxel affects the localization of DIABLO protein CTD PMID:18098270 paclitaxel increases expression ISO DIABLO (Homo sapiens) 6480464 Paclitaxel results in increased expression of DIABLO protein CTD PMID:17701358 paracetamol affects expression ISO Diablo (Mus musculus) 6480464 Acetaminophen affects the expression of DIABLO mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DIABLO mRNA CTD PMID:33387578 paracetamol increases transport ISO Diablo (Mus musculus) 6480464 Acetaminophen results in increased transport of DIABLO protein CTD PMID:28123000 paracetamol multiple interactions ISO Diablo (Mus musculus) 6480464 [NQO1 gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of DIABLO protein more ... CTD PMID:25224400 more ... paracetamol affects localization ISO Diablo (Mus musculus) 6480464 Acetaminophen affects the localization of DIABLO protein CTD PMID:17906064 more ... paracetamol increases expression ISO DIABLO (Homo sapiens) 6480464 Acetaminophen results in increased expression of DIABLO mRNA CTD PMID:25704631 paraquat multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [Paraquat affects the localization of DIABLO protein] more ... CTD PMID:17936647 and PMID:25947082 paraquat affects localization ISO DIABLO (Homo sapiens) 6480464 Paraquat affects the localization of DIABLO protein modified form CTD PMID:33383311 paraquat increases transport ISO DIABLO (Homo sapiens) 6480464 Paraquat results in increased transport of DIABLO protein CTD PMID:30205152 paraquat multiple interactions ISO DIABLO (Homo sapiens) 6480464 LGK974 inhibits the reaction [Paraquat results in increased transport of DIABLO protein] and oren gedoku to inhibits the reaction [Paraquat affects the localization of DIABLO protein modified form] CTD PMID:30205152 and PMID:33383311 paraquat affects localization EXP 6480464 Paraquat affects the localization of DIABLO protein CTD PMID:22245251 and PMID:25947082 paraquat increases expression EXP 6480464 Paraquat results in increased expression of DIABLO protein CTD PMID:17936647 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of DIABLO mRNA CTD PMID:19162173 perfluorooctanoic acid increases expression ISO DIABLO (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of DIABLO protein CTD PMID:26879310 phenethyl isothiocyanate affects binding ISO DIABLO (Homo sapiens) 6480464 DIABLO protein binds to phenethyl isothiocyanate CTD PMID:21838287 phenethyl isothiocyanate affects localization ISO DIABLO (Homo sapiens) 6480464 phenethyl isothiocyanate affects the localization of DIABLO protein CTD PMID:16054126 phenethyl isothiocyanate multiple interactions ISO DIABLO (Homo sapiens) 6480464 benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein] and Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein] CTD PMID:16054126 phenobarbital multiple interactions EXP 6480464 [3 more ... CTD PMID:27048571 propylparaben increases expression ISO DIABLO (Homo sapiens) 6480464 propylparaben results in increased expression of DIABLO mRNA CTD PMID:24481588 pterostilbene affects localization ISO DIABLO (Homo sapiens) 6480464 pterostilbene affects the localization of DIABLO protein CTD PMID:22572619 pterostilbene increases expression ISO DIABLO (Homo sapiens) 6480464 pterostilbene results in increased expression of DIABLO protein CTD PMID:22450950 and PMID:22572619 pyrroloquinoline quinone multiple interactions ISO DIABLO (Homo sapiens) 6480464 PQQ Cofactor inhibits the reaction [Rotenone results in increased expression of DIABLO protein] CTD PMID:26276080 quercetin increases expression ISO DIABLO (Homo sapiens) 6480464 Quercetin results in increased expression of DIABLO mRNA CTD PMID:20596804 quercetin affects localization ISO DIABLO (Homo sapiens) 6480464 Quercetin affects the localization of DIABLO protein CTD PMID:23918355 quercetin increases localization ISO DIABLO (Homo sapiens) 6480464 Quercetin results in increased localization of DIABLO protein CTD PMID:21138867 resveratrol affects localization ISO DIABLO (Homo sapiens) 6480464 resveratrol affects the localization of DIABLO protein CTD PMID:17636462 resveratrol decreases expression ISO Diablo (Mus musculus) 6480464 resveratrol results in decreased expression of DIABLO protein CTD PMID:17872969 resveratrol multiple interactions ISO DIABLO (Homo sapiens) 6480464 [resveratrol co-treated with Paclitaxel] affects the localization of DIABLO protein CTD PMID:14749477 resveratrol increases expression ISO Diablo (Mus musculus) 6480464 resveratrol results in increased expression of DIABLO protein CTD PMID:15837718 rotenone increases expression ISO DIABLO (Homo sapiens) 6480464 Rotenone results in increased expression of DIABLO protein CTD PMID:26276080 rotenone multiple interactions ISO DIABLO (Homo sapiens) 6480464 PQQ Cofactor inhibits the reaction [Rotenone results in increased expression of DIABLO protein] CTD PMID:26276080 SB 431542 multiple interactions ISO DIABLO (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIABLO mRNA CTD PMID:27188386 simvastatin affects localization ISO DIABLO (Homo sapiens) 6480464 Simvastatin affects the localization of DIABLO protein CTD PMID:20045437 simvastatin multiple interactions ISO DIABLO (Homo sapiens) 6480464 DIABLO protein promotes the reaction [Simvastatin results in increased activity of CASP9 protein] CTD PMID:20045437 sirolimus multiple interactions ISO DIABLO (Homo sapiens) 6480464 [7-hydroxystaurosporine co-treated with Sirolimus] affects the localization of DIABLO protein and Boc-D-FMK inhibits the reaction [[Sirolimus co-treated with 7-hydroxystaurosporine] affects the localization of DIABLO protein] CTD PMID:15767555 sodium dichromate increases transport ISO Diablo (Mus musculus) 6480464 sodium bichromate results in increased transport of DIABLO protein CTD PMID:20298709 sorafenib multiple interactions ISO DIABLO (Homo sapiens) 6480464 6-bromoindirubin-3'-oxime promotes the reaction [sorafenib affects the localization of DIABLO protein] more ... CTD PMID:17909059 and PMID:17991738 sorafenib affects localization ISO DIABLO (Homo sapiens) 6480464 Sorafenib affects the localization of DIABLO protein CTD PMID:17991738 spermine affects localization ISO DIABLO (Homo sapiens) 6480464 Spermine affects the localization of DIABLO protein CTD PMID:16151648 streptozocin multiple interactions ISO Diablo (Mus musculus) 6480464 [Streptozocin co-treated with NQO1 protein mutant form] results in increased secretion of DIABLO protein CTD PMID:23458895 T-2 toxin increases expression ISO DIABLO (Homo sapiens) 6480464 T-2 Toxin results in increased expression of DIABLO protein CTD PMID:34581912 thapsigargin affects response to substance ISO DIABLO (Homo sapiens) 6480464 DIABLO protein affects the susceptibility to Thapsigargin CTD PMID:16382148 thapsigargin increases expression ISO DIABLO (Homo sapiens) 6480464 Thapsigargin results in increased expression of DIABLO mRNA CTD PMID:22378314 thapsigargin affects localization ISO DIABLO (Homo sapiens) 6480464 Thapsigargin affects the localization of DIABLO protein CTD PMID:15339911 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DIABLO mRNA CTD PMID:23411599 trichostatin A decreases expression ISO DIABLO (Homo sapiens) 6480464 trichostatin A results in decreased expression of DIABLO mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO DIABLO (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIABLO mRNA CTD PMID:27188386 tunicamycin increases expression ISO DIABLO (Homo sapiens) 6480464 Tunicamycin results in increased expression of DIABLO mRNA CTD PMID:22378314 valproic acid affects expression ISO DIABLO (Homo sapiens) 6480464 Valproic Acid affects the expression of DIABLO mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of DIABLO mRNA CTD PMID:23555832 vincristine decreases expression ISO DIABLO (Homo sapiens) 6480464 Vincristine results in decreased expression of DIABLO mRNA CTD PMID:23649840 vitamin E multiple interactions ISO DIABLO (Homo sapiens) 6480464 Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein] and Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein] CTD PMID:15566391 and PMID:16054126 vorinostat multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Bortezomib co-treated with vorinostat] affects the localization of DIABLO protein CTD PMID:12893773 zidovudine multiple interactions ISO Diablo (Mus musculus) 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of DIABLO mRNA CTD PMID:18313992 zoledronic acid multiple interactions ISO DIABLO (Homo sapiens) 6480464 [Tretinoin co-treated with zoledronic acid] results in decreased expression of DIABLO protein CTD PMID:20349282